Junior Research Group

Pediatric Immuno-Oncology

  • Immunology, Infection and Cancer
  • KiTZ
  • Junior Research Group
Dr. Dr. Franziska Blaeschke

Dr. Dr. Franziska Blaeschke

Group Leader

Our junior research group investigates new immunotherapies for the treatment of childhood cancers.

Our Research

Our immune system is not only capable of fighting infections but can also, in principle, recognize and eliminate cancer cells. The principle of immunotherapy involves "training" the immune system to fight cancer. This is achieved, for example, through genetic modification of specific immune cells called T cells. These T cells can be engineered to carry a chimeric antigen receptor (CAR) on their surface. The resulting CAR T cells can then recognize and eliminate cancer cells in the patient’s body. This type of therapy has already been highly successful in treating children and adolescents with a specific type of blood cancer (lymphoblastic leukemia). Unfortunately, the therapy has so far been less effective for other forms of blood cancer (myeloid leukemia) and most solid tumors (e.g., brain tumors or bone tumors). We aim to change this! Our research projects focus on questions such as: What strategies have tumors developed to evade detection by the immune system? How can CAR T cells recruit other immune cells for help? How can we optimize T cells to effectively migrate to solid tumors and eliminate them?

The techniques performed in our laboratory include genetic engineering (e.g., using CRISPR/Cas9, lentiviruses, or retroviruses), cell culture, flow cytometry, CRISPR screens, next-generation sequencing, various tumor models, and functional analyses (e.g., characterizing CAR T cell function). Our projects are carried out in close collaboration with colleagues at the DKFZ, KiTZ, and UKHD, as well as with our national and international partners.

Together, we aim to unravel the functionality of immune cells in cancer and develop a new generation of immunotherapies for cancer treatment.

Team

We are an international team with expertise in genetic engineering, immunotherapy, tumor models, pediatrics, immunology, genomics, bioinformatics and CRISPR screens.

  • Employee image

    Dr. Dr. Franziska Blaeschke

    Group Leader

  • Employee image

    Dr. Oren Barboy

    Postdoc

  • Employee image

    Kathleen Grüter

    PhD Student

  • Employee image

    Eva Koitschev

    Master's Student

  • Employee image

    Monika Kuban

    Lab Manager

  • Employee image

    Konstantin Loher

    PhD Student

Open Positions

If you're interested in working with us, please reach out to franziska.blaeschke(at)kitz-heidelberg.de. Clinician scientists are encouraged to apply through the DKFZ Clinician Scientist Program: https://www.dkfz.de/en/karriere/dkfz-clinician-scientist-program/how-to-become-a-clinician-scientist-at-dkfz/research-profiles
 

Selected Publications

2023 - Cell
2022 - Nature
2022 - Science
2021 - Blood Cancer Journal

Get in touch with us

Employee image
Dr. Dr. Franziska Blaeschke
Group Leader
Form

Form data is loaded ...